Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Will Receive Nasdaq Delisting Warning if Shares Close Below $1 Today

NEW YORK, Sept. 15 (GenomeWeb News) - Sequenom will receive a delisting warning letter from the Nasdaq exchange if the company's share price closes below $1 today.


Sequenom's shares have been trading below $1 for the last 29 days, closing at $.89 yesterday. Nasdaq sends out delisting warning letters whenever a company's stock fails to keep the closing price of its shares at or above $1 for 30 consecutive trading days.


This is not the first time that Sequenom comes close to a Nasdaq warning. In December, the company missed a warning letter by a single day, and came similarly close in September of 2004.


Yesterday, the company said it will will lay off around 30 percent of its workforce, or 44 staffers, in a large-scale restructuring aimed at cutting costs and redirecting resources.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.